Press Releases
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC, and ASHG Conferences
October 2, 2023
10 abstracts accepted for presentation at three top genetic conferences, focusing on topics ranging from Whole Genome and Whole Exome Sequencing to Carrier Screening and Non-Invasive Prenatal Testing HOUSTON, TX (September 29, 2023), Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its scientists and genetic counselors will present 10…
September 12, 2023
New Test Analyzes Highly Curated Set of 236 Genes Most Associated with Autism Spectrum Disorder, Intellectual Disabilities, and Developmental Delay. HOUSTON, TX (September 12, 2023), Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental Disorders Panel for children and other patients affected by a…
July 11, 2023
Latest Panel Analyzes 397 Genes Associated with Several Epilepsy Conditions, Offering an Analysis of Well-studied, Actionable Genes Related to Many Syndromic and Non-syndromic Epileptic Disorders HOUSTON, TX (JULY 11, 2023), Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, today announced the availability of an Epilepsy Panel and a...
May 19, 2023
Baylor Genetics’ Latest Panel Analyzes 142 Genes Associated with Hereditary Neuromuscular Disorders HOUSTON, TX (May 15, 2023) – Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, today announced the availability of a Neuromuscular Disorder Panel. It offers a thorough analysis of 142 well-studied, actionable genes related to many...
August 9, 2022
Dear Valued Clients, Our promise to our providers and their patients is to offer the highest quality genetic testing services and make testing accessible for all. Now, with the click of a few buttons, providers can order our most popular tests from our online portal. To ensure the online portal is the most efficient and...
December 28, 2021
HOUSTON, TX (December 28, 2020) – Baylor Genetics and SRL, Inc. initiate clinical grade of whole exome and genome sequencing technology transfer Baylor Miraca Genetics Laboratories, LLC (BG), a clinical diagnostics laboratory known for genetic testing and precision medicine, and SRL, Inc., the largest lab for lab testing and its related services (LTS) in Japan,…
November 17, 2020
With the arrival of flu season, Baylor Genetics, a pioneer of genetic testing and precision medicine, has launched the latest combination test for the novel coronavirus, SARS-CoV-2, and Influenza A and B. “Baylor Genetics created the combination COVID-19 and flu test because the symptoms between the two are so similar, but the treatments are undeniably…
October 6, 2020
Baylor Genetics, a clinical diagnostics laboratory known for genetic testing and precision medicine, announced its launch of an accessible and reliable at-home collection kit for COVID-19. With the launch of the at-home test, individuals nationwide will be able to order a test kit to determine if they are currently infected with COVID-19 within 48 hours…
August 12, 2020
FOR IMMEDIATE RELEASE Baylor Genetics and Rice University Form COVID-19 Screening Partnership for the Fall Semester; Partnership Aims for ‘Moon-Shot’ 48-Hours-or-Less Turnaround for Test Results Houston, TX (August 13, 2020) – Baylor Genetics, a clinical diagnostics laboratory known for genetic testing and precision medicine, and Rice University, a private, comprehensive research university located in Houston, TX, have partnered together to create a first-of-its kind total turnkey solution for the university to resume…
July 23, 2020
HOUSTON, TX (July 23, 2020) – In response to the global pandemic, Baylor Genetics, a pioneer in genetic testing and precision medicine, launched its official test for COVID-19 on June 16, 2020. To help prevent the spread of COVID-19 in Houston, Texas, Baylor Genetics has partnered with the Houston Health Department, City of Houston (COH),…
June 16, 2020
Houston, TX (June 16, 2020) – In response to the global pandemic, Baylor Genetics, a pioneer of genetic testing and precision medicine, launched its official test for COVID-19. “For over 40 years, Baylor Genetics has focused on improving people’s lives by creating innovative tests. I can confidently state that innovation continues to be our focus,...
May 10, 2019
FOR IMMEDIATE RELEASE Baylor Genetics and King Faisal Specialist Hospital – Saudi Diagnostic Limited Sign Memorandum of Understanding (MOU) to Build Strategic Partnership for All Genetic Testing and Precision Medicine HOUSTON, TEXAS / RIYADH, KINGDOM OF SAUDI ARABIA (May 10, 2019) – Houston-based Baylor Genetics (BG) and Riyadh-based Saudi Diagnostic Limited (SDL), a subsidiary of…
February 4, 2019
FOR IMMEDIATE RELEASE Baylor Genetics Launches Clinical Whole Genome Sequencing HOUSTON, TX (Feb. 4, 2019) – Baylor Genetics, a leader in genetic testing, announced today the launch of clinical whole genome sequencing (WGS) for the diagnosis of rare genetic and inherited disorders. “For the past two decades, Baylor Genetics has been pioneering the field…
March 6, 2018
Note: ClariFind has been discontinued at Baylor Genetics. Houston, TX – March 6, 2018 – Baylor Genetics announces today the launch of ClariFind, a comprehensive somatic tumor next-generation sequencing test that correlates genomic results with specific drug therapies and clinical trial options. Baylor Genetics’ experts, in collaboration with Baylor College of Medicine, developed ClariFind to…
November 9, 2017
CHICAGO – Nov. 9, 2017 – Social and regular media are filled with information about all the genetic tests available and the latest genes discovered by researchers. You can’t help but wonder whether you should be tested and what the results might mean. So where do you turn? Genetic counselors are the professionals who can…
September 24, 2017
Hong Kong / Houston, Texas – Baylor Genetics announces a partnership with Hong Kong-based Rainbow Genomics to provide clinical whole exome sequencing tests to patients in Hong Kong, Japan, Singapore and other Asian countries. Product offering includes adult exome screening, high-risk cancer and wellness cancer tests. Unlike many “recreational” consumer genetic tests currently available in…
August 17, 2017
South San Francisco, California / Houston, Texas – Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a next-generation sequencing (NGS) library prep assay that enables efficient sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Under the agreement, Fluidigm obtains the rights to commercialize…
September 20, 2016
San Diego, California / Houston, Texas – Baylor Genetics Selects Edico Genome’s DRAGEN to Improve Turnaround Times for Clinical Tests, Enabling Physicians and Genetic Counselors to be ‘Ready with Answers’ Faster Than Ever. Baylor Genetics, a genetics laboratory specializing in the development and commercialization of the highest quality genetic testing and genomic lab testing, today…
September 20, 2016
San Diego, California / Houston, Texas – Baylor Genetics Selects Edico Genome’s DRAGEN to Improve Turnaround Times for Clinical Tests, Enabling Physicians and Genetic Counselors to be ‘Ready with Answers’ Faster Than Ever. Baylor Genetics, a genetics laboratory specializing in the development and commercialization of the highest quality genetic testing and genomic lab testing, today…
February 23, 2016
Houston, Texas – Baylor Miraca today announced a strategic partnership with Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, to provide its customers access to a broad range of targeted genomics and metabolomics services. The two companies, both commercial endeavors of Baylor College of Medicine, are leveraging the scientific acumen and research infrastructure…
November 17, 2015
Houston, Texas – Baylor Genetics has entered into an agreement with Oxford Gene Technology (OGT), The Molecular Genetics Company, to license the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. As part of the agreement, Baylor Genetics will utilize aCGH arrays containing both copy number variation (CNV) and SNP probes to identify…
May 14, 2015
Houston, Texas – Baylor Genetics announced today the launch of an enhanced clinical exome sequencing test, a new option for physicians that speeds up delivery of final results to two-three weeks from three months. The test, called CriticalWES trio, brings industry best turnaround time to a test already known for its superior coverage and content….